A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

Bristol-Myers Squibb

Overview

The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Conditions

Diabetes Mellitus, Non-Insulin-Dependent

Interventions

Glucovance (metformin HCl/glyburide)DRUG

metformin HClDRUG

glyburideDRUG

Eligibility

Sex: ALLMin age: 9 YearsMax age: 16 Years

Medical Language ↔ Plain English

Children ages 9-16 years with a diagnosis of type 2 diabetes mellitus who are not adequately controlled with diet and exercise, with or without oral hypoglycemic therapy, and have an HbA1c greater than 6.4%

Locations (50)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Childrens's Health System/Dept of PED/Diabetes/Endoncrinology

Birmingham, Alabama, United States

Advanced Clinical Therapeutics

Tucson, Arizona, United States

Hazan, Lydie

Beverly Hills, California, United States

Bautista Research & Medical Center

Fresno, California, United States

Health Care Link, Inc

La Jolla, California, United States

Neufeld Medical Group

Los Angeles, California, United States

National Institute Of Clinical Research

Los Angeles, California, United States

Pasadena Pediatric Endocrinology Diabetes

Pasadena, California, United States

A.R.I. Clinical Trials

Redondo Beach, California, United States

Sutter Institute For Medical Research

Sacramento, California, United States

...and 40 more locations